| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |